CATEGORY : Clinical Diagnostics

Life Science Market Reports

Our life science market intelligence products have been recognized by market insiders and outsiders alike for their accuracy, in-depth analysis, and unique insights.

Market Reports

An Updated Look at TMB: What Has Changed and What to Expect

Since we last reported on the rise of tumor mutational burden (TMB) in immuno-oncology (I/O) a year ago, there have been numerous material developments of this biomarker in the I/O

View Details

Pulse Survey: Adoption and Utilization of Next Generation Cancer Biomarkers

The way cancer is diagnosed, treated, and monitored is changing more rapidly than ever. In 2019, we expect there to be catalysts that fundamentally change cancer companion diagnostic biomarker testing (i.e.,

View Details

Guardant Health stock soars after IPO, Lexent Bio joins the serial monitoring gold rush and a UK research team develops a novel cfDNA assay

Want to keep up with the latest liquid biopsy market research developments? Take our 6 minute survey and sign up for our weekly newsletter. DeciBio Liquid Biopsy Weekly Digest September 27, 2018

View Details

New CRISPR Companies Heat Up as Skepticism Grows

Novel ways of harnessing CRISPR disrupt diagnostics, therapeutics, and food systems While much hype has been built around CRISPR-Cas9 and its ability to revolutionize treatment of genetic disorders and disease,

View Details

Exploring Collaboration Networks within Liquid Biopsy Research

Background Network graphs have always amazed me. This concept has been around for a long time now and has been leveraged by scientists to explain a wide variety of phenomena

View Details

ASCO 2018 Summary Highlights

Is Neoantigen Load the next TMB? The rise of cfRNA and the Saturation of the Liquid Biopsy Landscape Another ASCO Annual Meeting has come to a close and, though this

View Details

Liquid Biopsy Trends to Watch at ASCO 2018

Guardant leads, Grail makes strides with CCGA, and more Over 39,000 attendees are expected to descend upon McCormick Place in just one short week. The theme for this year’s conference,

View Details

AACR 2018 Summary Highlights

Chicago, IL April 19, 2018 – Another AACR meeting has come to a close and, as always, has yielded a myriad of perspectives, developments, product launches, and clinical advancements. While

View Details

Liquid Biopsy Updates: Oncotype SEQ Drops Out, ASCO / CAP Release Joint Report, NCD Bodes Well for Some

Recent commotion in liquid biopsy space highlights challenges and successes As usual, there has been a lot of commotion in the liquid biopsy market space over the past few weeks.

View Details

How can we help?

Avoid blind spots in your market. Get the insights you need to accelerate innovation.

Contact Us